1.
|
Phase: Phase III, Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: RTOG-9802, E-R9802, NCCTG-R9802, SWOG-R9802, RTOG-DEV-1012, NCT00003375, RTOG-98-02
|
|
2.
|
Phase: Phase III, Phase II Type: Treatment Status: Closed Age: under 60 Sponsor: Protocol IDs: EORTC-LAM-4
|
|
3.
|
Phase: Phase III, Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-86-C-92A, NCI-NMOB-855, NCI-T86-0137N, T86-0137
|
|
4.
|
Phase: Phase III Type: Treatment Status: Closed Age: over 16 Sponsor: Protocol IDs: EORTC-26921
|
|
5.
|
Phase: Phase III Type: Treatment Status: Closed Age: under 75 Sponsor: Protocol IDs: MRC-BR03, EU-94010
|
|
6.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: RTOG-9404, NCCTG-947251, SWOG-9340, RTOG-94-04
|
|
7.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: RTOG-9402, CAN-NCIC-CE2, E-R9402, NCCTG-927252, SWOG-9402, INT-0149, NCT00002569, CE2
|
|
8.
|
Phase: Phase III Type: Treatment Status: Closed Age: 70 and under Sponsor: Protocol IDs: MRC-LU03, EU-94018
|
|
9.
|
Phase: Phase III Type: Treatment Status: Closed Age: 70 and under Sponsor: Protocol IDs: MRC-LU04, EU-94019
|
|
10.
|
Phase: Phase III Type: Treatment Status: Closed Age: 20 to 70 Sponsor: Protocol IDs: MSHMC-REN-2
|
|
11.
|
Phase: Phase III Type: Treatment Status: Completed Age: 16 to 69 Sponsor: Other Protocol IDs: EORTC-26951, MRC-BR11, NCT00002840
|
|
12.
|
Phase: Phase III Type: Treatment Status: Completed Age: 3 to 21 at diagnosis Sponsor: NCI Protocol IDs: CCG-A9961, POG-A9961, NCT00002875, A9961
|
|
13.
|
Phase: Phase III Type: Treatment Status: Completed Age: Under 10 Sponsor: NCI Protocol IDs: COG-A9952, CCG-A9952, POG-A9952, CCG-9952, A9952, NCT00002944
|
|
14.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: RHG-MM97, EU-98030, NCT00003603
|
|
15.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: HEALTHONE-43892, HEALTHONE-1A, HEALTHONE-CA43892, RPCI-DS-9802, NCI-V99-1525, NCT00003788
|
|
16.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: RTOG-9813, ECOG-R9813, NCCTG-RTOG-9813, RTOG-98-13, NCT00004259
|
|
17.
|
Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: CHNMC-COH-CA-LUN-1, NCI-D80-035-131
|
|
18.
|
Phase: Phase III Type: Treatment Status: Completed Age: no age specified Sponsor: NCI Protocol IDs: SWOG-7701
|
|
19.
|
Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: UMCC-7312A
|
|
20.
|
Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: WCG-119
|
|
21.
|
Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: WCG-120
|
|
22.
|
Phase: Phase III Type: Treatment Status: Completed Age: over 18 Sponsor: Protocol IDs: WCG-130
|
|
23.
|
Phase: Phase III Type: Treatment Status: Closed Age: under 75 Sponsor: Protocol IDs: WFU-62277
|
|
24.
|
Phase: Phase III Type: Treatment Status: Completed Age: under 20 Sponsor: NCI Protocol IDs: CCG-243
|
|
25.
|
Phase: Phase III Type: Treatment Status: Completed Age: over 16 Sponsor: NCI Protocol IDs: CLB-7751
|